These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 3501454)

  • 21. [Clinical trial of oral immunotherapy with streptococcal preparation OK 432 on gastric cancer].
    Nio Y; Ohgaki K; Henmi K; Kan N; Inamoto T; Tsuchitani T; Kodama H; Tobe T
    Nihon Gan Chiryo Gakkai Shi; 1982 Apr; 17(3):728-34. PubMed ID: 6752308
    [No Abstract]   [Full Text] [Related]  

  • 22. [A basic study of combination cancer immunotherapy with OK-432 and rIL-2--induction of lymphokine-activated killer (LAK) precursor cells in murine spleen by intravenous administration of OK-432].
    Shimoda K; Saito T; Kobayashi M
    Nihon Gan Chiryo Gakkai Shi; 1988 Jul; 23(7):1566-73. PubMed ID: 3263451
    [No Abstract]   [Full Text] [Related]  

  • 23. [Oral administration of streptococcal preparation "OK 432"--the 4th report: augmentation of in vitro anti-tumor immune responses of mice with transplanted cecal tumor].
    Tsuchitani T; Kodama H; Tobe T; Nio Y; Kan N; Inamoto T
    Nihon Gan Chiryo Gakkai Shi; 1984 Oct; 19(9):2179-87. PubMed ID: 6530585
    [No Abstract]   [Full Text] [Related]  

  • 24. Antitumor activity of a Streptococcus pyogenes preparation (OK-432). II. Analysis of the cytotoxic lymphocytes induced by OK-432 injection into tumor-bearing F344 rats.
    Fukui H; Reynolds CW
    J Natl Cancer Inst; 1987 Nov; 79(5):1019-24. PubMed ID: 3500354
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Purification and biological activities of a mouse serum protein increased by administration of streptococcal preparation, OK-432.
    Torikai T; Itoh O; Toyoshima S; Osawa T
    Gan; 1978 Oct; 69(5):657-65. PubMed ID: 729964
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of biological response modifier-streptococcal preparation OK-432 on NK/K cell system of gnotobiotic miniature swine.
    Kim YB
    Prog Clin Biol Res; 1985; 181():337-41. PubMed ID: 4063011
    [No Abstract]   [Full Text] [Related]  

  • 27. Reduction of suppressor cell activities of human peripheral blood lymphocytes by a streptococcal preparation, OK-432.
    Toge T; Yamada H; Aratani K; Yamaguchi M; Fujita T; Yanagawa E; Hattori T
    Int J Immunopharmacol; 1987; 9(8):875-9. PubMed ID: 2892805
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro potentiation of human natural killer cell activity by a streptococcal preparation, OK-432: interferon and interleukin-2 participation in the stimulation with OK-432.
    Wakasugi H; Kasahara T; Minato N; Hamuro J; Miyata M; Morioka Y
    J Natl Cancer Inst; 1982 Oct; 69(4):807-12. PubMed ID: 6181282
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Natural killer (NK) cell activating factor released from murine thymocytes stimulated with an anti-tumor streptococcal preparation, OK-432.
    Shitara K; Ichimura O; Mitsuno T; Osawa T
    J Immunol; 1985 Feb; 134(2):1039-47. PubMed ID: 2578148
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies on the immunopotentiating effects of a streptococcal preparation, OK-432. I. Enhancement of T cell-mediated immune responses of mice.
    Kai S; Tanaka J; Nomoto K; Torisu M
    Clin Exp Immunol; 1979 Jul; 37(1):98-105. PubMed ID: 314874
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Immunohistological studies of the skin at the injection site of cases receiving the streptococcal agent OK-432].
    Hanaue H; Kurosawa T; Miyakawa S; Horie F; Nemoto A; Yamoto H; Nishimura S; Tsuchiya H; Miura S; Asagoe T
    Nihon Gan Chiryo Gakkai Shi; 1985 Dec; 20(10):2271-8. PubMed ID: 3879494
    [No Abstract]   [Full Text] [Related]  

  • 32. Mechanism of polymorphonuclear leukocytes accumulation examined using inhibitors of complement and arachidonic acid cascade in rats treated with OK-432.
    Kato H; Inoue M; Yamamura Y; Tanigawa M; Sano H; Sugino S; Kondo M
    Nat Immun Cell Growth Regul; 1989; 8(5):290-300. PubMed ID: 2512482
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of a streptococcal preparation on the complement system.
    Kato H; Yokoe N; Matsumura N; Nishida K; Ikezaki M; Hosokawa K; Hotta T; Takemura S; Yoshikawa T; Kondo M
    Jpn J Exp Med; 1979 Oct; 49(5):343-50. PubMed ID: 529490
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Inhibition of pulmonary metastasis in mice by OK-432--MCT emulsion administrated enterally].
    Masuyama K; Tazawa K; Kasagi T; Yamashita I; Ishizawa S; Fujimaki M; Ochiai H; Niwayama S; Matsui H
    Nihon Gan Chiryo Gakkai Shi; 1988 Jun; 23(6):1300-6. PubMed ID: 3230345
    [No Abstract]   [Full Text] [Related]  

  • 35. Stable long-term induction of perforin-positive CD8+ T cells in gut by oral administration of streptococcal preparation OK-432.
    Mino N; Naomoto Y; Shirakawa Y; Matsuoka J; Nobuhisa T; Gunduz M; Noma K; Nagatsuka H; Kobayashi M; Yamatsuji T; Haisa M; Gochi A; Tanaka N
    Int J Mol Med; 2004 Nov; 14(5):801-6. PubMed ID: 15492848
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The identification of sera distinguishing marrow-derived and thymus-derived lymphocytes in the rat thoracic duct.
    Howard JC; Scott DW
    Immunology; 1974 Nov; 27(5):903-22. PubMed ID: 4611909
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation and augmentation of guinea pig macrophages with streptococcal preparation OK-432 and stimulated spleen cell products.
    Onozaki K; Suzuki K; Fukutomi Y; Yagami K; Hashimoto T
    J Reticuloendothel Soc; 1982 Dec; 32(6):433-42. PubMed ID: 6761439
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Evaluation of the routes of administration of a streptococcal preparation, OK-432--with special reference to augmentation of the natural killer cell activity].
    Hosoi J; Wakasugi H; Miyata M; Minato N; Imai M
    Nihon Gan Chiryo Gakkai Shi; 1982 Dec; 17(8):2044-55. PubMed ID: 7169577
    [No Abstract]   [Full Text] [Related]  

  • 39. [Combined effects of cis-DDP and OK-432 on ascitic mastocytoma in mice: optimal period for the administration of OK-432].
    Komatsu K; Nakamura W
    C R Seances Soc Biol Fil; 1986; 180(1):117-20. PubMed ID: 2943364
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Augmentation by OK-432 of generation of culture-induced killer cells.
    Ujiie T
    Jpn J Exp Med; 1987 Jun; 57(3):153-61. PubMed ID: 3682231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.